Cargando…
NASH-related increases in plasma bile acid levels depend on insulin resistance
BACKGROUND & AIMS: Plasma bile acids (BAs) have been extensively studied as pathophysiological actors in non-alcoholic steatohepatitis (NASH). However, results from clinical studies are often complicated by the association of NASH with type 2 diabetes (T2D), obesity, and insulin resistance (IR)....
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878982/ https://www.ncbi.nlm.nih.gov/pubmed/33615207 http://dx.doi.org/10.1016/j.jhepr.2020.100222 |
_version_ | 1783650437991235584 |
---|---|
author | Grzych, Guillaume Chávez-Talavera, Oscar Descat, Amandine Thuillier, Dorothée Verrijken, An Kouach, Mostafa Legry, Vanessa Verkindt, Hélène Raverdy, Violeta Legendre, Benjamin Caiazzo, Robert Van Gaal, Luc Goossens, Jean-Francois Paumelle, Réjane Francque, Sven Pattou, François Haas, Joel T. Tailleux, Anne Staels, Bart |
author_facet | Grzych, Guillaume Chávez-Talavera, Oscar Descat, Amandine Thuillier, Dorothée Verrijken, An Kouach, Mostafa Legry, Vanessa Verkindt, Hélène Raverdy, Violeta Legendre, Benjamin Caiazzo, Robert Van Gaal, Luc Goossens, Jean-Francois Paumelle, Réjane Francque, Sven Pattou, François Haas, Joel T. Tailleux, Anne Staels, Bart |
author_sort | Grzych, Guillaume |
collection | PubMed |
description | BACKGROUND & AIMS: Plasma bile acids (BAs) have been extensively studied as pathophysiological actors in non-alcoholic steatohepatitis (NASH). However, results from clinical studies are often complicated by the association of NASH with type 2 diabetes (T2D), obesity, and insulin resistance (IR). Here, we sought to dissect the relationship between NASH, T2D, and plasma BA levels in a large patient cohort. METHODS: Four groups of patients from the Biological Atlas of Severe Obesity (ABOS) cohort (Clinical Trials number NCT01129297) were included based on the presence or absence of histologically evaluated NASH with or without coincident T2D. Patients were matched for BMI, homeostatic model assessment 2 (HOMA2)-assessed IR, glycated haemoglobin, age, and gender. To study the effect of IR and BMI on the association of plasma BA and NASH, patients from the HEPADIP study were included. In both cohorts, fasting plasma BA concentrations were measured. RESULTS: Plasma BA concentrations were higher in NASH compared with No-NASH patients both in T2D and NoT2D patients from the ABOS cohort. As we previously reported that plasma BA levels were unaltered in NASH patients of the HEPADIP cohort, we assessed the impact of BMI and IR on the association of NASH and BA on the combined BA datasets. Our results revealed that NASH-associated increases in plasma total cholic acid (CA) concentrations depend on the degree of HOMA2-assessed systemic IR, but not on β-cell function nor on BMI. CONCLUSIONS: Plasma BA concentrations are elevated only in those NASH patients exhibiting pronounced IR. LAY SUMMARY: Non-alcoholic steatohepatitis (NASH) is a progressive liver disease that frequently occurs in patients with obesity and type 2 diabetes. Reliable markers for the diagnosis of NASH are needed. Plasma bile acids have been proposed as NASH biomarkers. Herein, we found that plasma bile acids are only elevated in patients with NASH when significant insulin resistance is present, limiting their utility as NASH markers. |
format | Online Article Text |
id | pubmed-7878982 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-78789822021-02-18 NASH-related increases in plasma bile acid levels depend on insulin resistance Grzych, Guillaume Chávez-Talavera, Oscar Descat, Amandine Thuillier, Dorothée Verrijken, An Kouach, Mostafa Legry, Vanessa Verkindt, Hélène Raverdy, Violeta Legendre, Benjamin Caiazzo, Robert Van Gaal, Luc Goossens, Jean-Francois Paumelle, Réjane Francque, Sven Pattou, François Haas, Joel T. Tailleux, Anne Staels, Bart JHEP Rep Research Article BACKGROUND & AIMS: Plasma bile acids (BAs) have been extensively studied as pathophysiological actors in non-alcoholic steatohepatitis (NASH). However, results from clinical studies are often complicated by the association of NASH with type 2 diabetes (T2D), obesity, and insulin resistance (IR). Here, we sought to dissect the relationship between NASH, T2D, and plasma BA levels in a large patient cohort. METHODS: Four groups of patients from the Biological Atlas of Severe Obesity (ABOS) cohort (Clinical Trials number NCT01129297) were included based on the presence or absence of histologically evaluated NASH with or without coincident T2D. Patients were matched for BMI, homeostatic model assessment 2 (HOMA2)-assessed IR, glycated haemoglobin, age, and gender. To study the effect of IR and BMI on the association of plasma BA and NASH, patients from the HEPADIP study were included. In both cohorts, fasting plasma BA concentrations were measured. RESULTS: Plasma BA concentrations were higher in NASH compared with No-NASH patients both in T2D and NoT2D patients from the ABOS cohort. As we previously reported that plasma BA levels were unaltered in NASH patients of the HEPADIP cohort, we assessed the impact of BMI and IR on the association of NASH and BA on the combined BA datasets. Our results revealed that NASH-associated increases in plasma total cholic acid (CA) concentrations depend on the degree of HOMA2-assessed systemic IR, but not on β-cell function nor on BMI. CONCLUSIONS: Plasma BA concentrations are elevated only in those NASH patients exhibiting pronounced IR. LAY SUMMARY: Non-alcoholic steatohepatitis (NASH) is a progressive liver disease that frequently occurs in patients with obesity and type 2 diabetes. Reliable markers for the diagnosis of NASH are needed. Plasma bile acids have been proposed as NASH biomarkers. Herein, we found that plasma bile acids are only elevated in patients with NASH when significant insulin resistance is present, limiting their utility as NASH markers. Elsevier 2020-12-16 /pmc/articles/PMC7878982/ /pubmed/33615207 http://dx.doi.org/10.1016/j.jhepr.2020.100222 Text en © 2021 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Research Article Grzych, Guillaume Chávez-Talavera, Oscar Descat, Amandine Thuillier, Dorothée Verrijken, An Kouach, Mostafa Legry, Vanessa Verkindt, Hélène Raverdy, Violeta Legendre, Benjamin Caiazzo, Robert Van Gaal, Luc Goossens, Jean-Francois Paumelle, Réjane Francque, Sven Pattou, François Haas, Joel T. Tailleux, Anne Staels, Bart NASH-related increases in plasma bile acid levels depend on insulin resistance |
title | NASH-related increases in plasma bile acid levels depend on insulin resistance |
title_full | NASH-related increases in plasma bile acid levels depend on insulin resistance |
title_fullStr | NASH-related increases in plasma bile acid levels depend on insulin resistance |
title_full_unstemmed | NASH-related increases in plasma bile acid levels depend on insulin resistance |
title_short | NASH-related increases in plasma bile acid levels depend on insulin resistance |
title_sort | nash-related increases in plasma bile acid levels depend on insulin resistance |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7878982/ https://www.ncbi.nlm.nih.gov/pubmed/33615207 http://dx.doi.org/10.1016/j.jhepr.2020.100222 |
work_keys_str_mv | AT grzychguillaume nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT chaveztalaveraoscar nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT descatamandine nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT thuillierdorothee nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT verrijkenan nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT kouachmostafa nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT legryvanessa nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT verkindthelene nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT raverdyvioleta nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT legendrebenjamin nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT caiazzorobert nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT vangaalluc nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT goossensjeanfrancois nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT paumellerejane nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT francquesven nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT pattoufrancois nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT haasjoelt nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT tailleuxanne nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance AT staelsbart nashrelatedincreasesinplasmabileacidlevelsdependoninsulinresistance |